Aug 2026· The American surgeon· pp.
31348261480818
· 0 citations· 14 references
Medicine
TL;DR
There was an increased risk of developing TC in all groups, and Black patients had the highest HR highlighting an area that warrants further investigation, and Black patients had the highest HR highlighting an area that warrants further investigation.
Abstract
BackgroundSmoking is a known carcinogen and its relationship with the development of thyroid cancer (TC) is not well established and prior evidence shows a possible protective relationship. We aim to evaluate the impact of smoking on the development of TC.MethodsThis is a retrospective cohort study of adult patients who were diagnosed with a thyroid nodule(s) between 2005 and 2025. Cohorts were developed based on smoking status. Patients with the diagnosis of multiple endocrine neoplasia syndrome or who had known TC were excluded. Propensity score matching (PSM) was performed. The primary outcome was diagnosis of TC. Hazard ratios (HRs) and 95% confidence intervals were calculated. Cohorts were then divided into subgroups based on sex and racial groups with the same analysis.ResultsThere were 404,811 individuals identified who were smokers and had thyroid nodules. Average age was 60 +/- 15 years, with 69% of the cohort being female and 70% white. TC developed in 3.4% of smokers with nodules compared to 1.2% of nonsmokers (HR = 2.60). Subgroup analysis revealed an increased risk across all sex and racial groups. Female smokers had a HR than males at 2.62. Across racial groups, Black patients had the highest HR at 2.91. All groups had confidence intervals that did not cross one.DiscussionIn this retrospective cohort study, smoking was significantly associated with an increased risk of developing TC. There was an increased risk of developing TC in all groups, and Black patients had the highest HR highlighting an area that warrants further investigation.
It is concluded that high levels of free T3, and a high free T3/T4 ratio were associated with a lower risk of all‐cause mortality and may be a marker of a favourable prognosis.
Annie Brange, Ylva Heyman, Kamil Demircan et al.· Cancer Medicine· 0 citations
Higher BMI is independently associated with thyroid malignancy in GD and may serve as a clinically relevant adjunctive risk marker and support more individualized surgical decision-making in patients with GD.
O. Çalişkan, M. T. Unlu, I. Çetinoğlu et al.· The Laryngoscope· 0 citations
The risk of recurrence and death was significantly higher in older age, men, smokers, tumors larger than 4 cm and regional lymph node and regional lymph node, and for each additional year of life the risk of recurrence and death increased by 4% and 9%, respectively.
Background Family history of cancer is an established risk factor for lung cancer, but its association with the probability of malignancy among patients evaluated for pulmonary nodules—rather than with population-level lung cancer incidence—remains poorly characterized in Chinese populations. Methods We conducted a ret...
Hong-Jun Song, Xin-Lu Men, Jun Cheng et al.· Frontiers in Medicine· 0 citations
Smoking exposure, occupational hazards, unhealthy indoor environments, and chronic pulmonary diseases are important determinants of lung cancer in North Sumatra and public health strategies focusing on tobacco control, improved workplace safety, and reduction of indoor air pollution may substantially reduce lung cancer...
Putri Aulia Anwar, Noni Novisari Soeroso, Setia Putra Tarigan et al.· Experimental oncology· 0 citations
This nomogram provides a population-level estimate of DSS in advanced FTC and may support preliminary risk stratification using readily available registry variables, but its clinical interpretation should consider the absence of key biologic and treatment-response factors not captured in SEER, including vascular invasi...
A. Şanlı, Isa Karaca, Bilal Turan et al.· The American surgeon· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.